These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

40 related articles for article (PubMed ID: 3218361)

  • 1. [Production of monoclonal antibodies against differentiation antigens of the exocrine pancreas].
    Sinn HP; Brown SA; Oberle E; Jennings CD; Thompson JS
    Verh Dtsch Ges Pathol; 1988; 72():369-73. PubMed ID: 3218361
    [No Abstract]   [Full Text] [Related]  

  • 2. Human leukocyte differentiation antigens.
    Bernard A; Horejsi V
    J Immunol; 1989 Aug; 143(3):1073. PubMed ID: 2745975
    [No Abstract]   [Full Text] [Related]  

  • 3. Cell differentiation in pancreatic cancer.
    Warren JR; Chien JL
    Ann Clin Lab Sci; 1983; 13(4):281-8. PubMed ID: 6312868
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monoclonal antibody-defined human pancreatic cancer-associated antigens.
    Schmiegel WH; Kalthoff H; Arndt R; Gieseking J; Greten H; Klöppel G; Kreiker C; Ladak A; Lampe V; Ulrich S
    Cancer Res; 1985 Mar; 45(3):1402-7. PubMed ID: 3882225
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differentiation antigens of human articular chondrocytes and their tissue distribution as assessed by monoclonal antibodies.
    Yamaga KM; Kimura LH; Plymyer MR; Glant TT; Lance EM
    J Autoimmun; 1994 Apr; 7(2):203-17. PubMed ID: 8037839
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lex and Ley antigen expression in human pancreatic cancer.
    Kim YS; Itzkowitz SH; Yuan M; Chung Y; Satake K; Umeyama K; Hakomori S
    Cancer Res; 1988 Jan; 48(2):475-82. PubMed ID: 3335015
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human pancreatic cancer-associated antigens detected by murine monoclonal antibodies.
    Yuan SZ; Ho JJ; Yuan M; Kim YS
    Cancer Res; 1985 Dec; 45(12 Pt 1):6179-87. PubMed ID: 4063969
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Six monoclonal antibodies to human pancreatic cancer antigens.
    Kajiji SM; Davceva B; Quaranta V
    Cancer Res; 1987 Mar; 47(5):1367-76. PubMed ID: 3815343
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of swine leukocyte differentiation antigens.
    Saalmüller A
    Immunol Today; 1996 Aug; 17(8):352-4. PubMed ID: 8783492
    [No Abstract]   [Full Text] [Related]  

  • 10. Monoclonal antibodies against human pancreatic adenocarcinoma: distribution of DU-PAN-2 antigen on glandular epithelia and adenocarcinomas.
    Borowitz MJ; Tuck FL; Sindelar WF; Fernsten PD; Metzgar RS
    J Natl Cancer Inst; 1984 May; 72(5):999-1005. PubMed ID: 6371347
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Osteoclast differentiation antigen.
    Kukita T; Kukita A
    Histol Histopathol; 1996 Jul; 11(3):821-30. PubMed ID: 8839769
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differentiation status of rat ductal cells and ethionine-induced hepatic carcinomas defined with surface-reactive monoclonal antibodies.
    Hixson DC; Brown J; McBride AC; Affigne S
    Exp Mol Pathol; 2000 Jun; 68(3):152-69. PubMed ID: 10816384
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel monoclonal antibody specific for biliary glycoprotein (CD66a).
    Dráberová L; Stanners CP; Dráber P
    Folia Biol (Praha); 1997; 43(6):243-4. PubMed ID: 9595268
    [No Abstract]   [Full Text] [Related]  

  • 14. CTLA-4 blockade: autoimmunity as treatment.
    Kapadia D; Fong L
    J Clin Oncol; 2005 Dec; 23(35):8926-8. PubMed ID: 16204008
    [No Abstract]   [Full Text] [Related]  

  • 15. Biologic and immunomodulatory events after CTLA-4 blockade with ticilimumab in patients with advanced malignant melanoma.
    Reuben JM; Lee BN; Li C; Gomez-Navarro J; Bozon VA; Parker CA; Hernandez IM; Gutierrez C; Lopez-Berestein G; Camacho LH
    Cancer; 2006 Jun; 106(11):2437-44. PubMed ID: 16615096
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel approach for obtaining and identifying monoclonal antibodies that react with differentiation-specific antigens using human hybrid cells.
    Stanbridge EJ; Araujo D; Ross P; Butler G; McCullough J; Wilkinson J
    Cancer Res; 1986 Sep; 46(9):4759-64. PubMed ID: 3731123
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CTLA-4 blockade: unveiling immune regulation.
    Dranoff G
    J Clin Oncol; 2005 Feb; 23(4):662-4. PubMed ID: 15613692
    [No Abstract]   [Full Text] [Related]  

  • 18. Reactivity of the workshop CD5 panel antibodies with the purified CD5 antigen.
    Letesson JJ; Lambot M; Mulumba M; Depelchin A
    Vet Immunol Immunopathol; 1991 Jan; 27(1-3):241. PubMed ID: 1708552
    [No Abstract]   [Full Text] [Related]  

  • 19. Reactivity of the workshop CD5 panel antibodies on western blot of cell lysate.
    Letesson JJ; Mulumba M; Depelchin A
    Vet Immunol Immunopathol; 1991 Jan; 27(1-3):239. PubMed ID: 1708551
    [No Abstract]   [Full Text] [Related]  

  • 20. Site-directed in vitro immunization leads to a complete human monoclonal IgG4 lambda that binds specifically to the CDR2 region of CTLA-4 (CD152) without interfering the engagement of natural ligands.
    Chin LT; Chu C; Chen HM; Hsu SC; Weng BC; Chu CH
    BMC Biotechnol; 2007 Aug; 7():51. PubMed ID: 17714596
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 2.